Swift Medical Closes $8 Million Financing for AI-Based Wound Care Technology

Toronto-based Swift Medical has closed $8 million round of financing led by BDC Capital’s Women in Technology Venture Fund and funds managed by Virgo Investment Group.

Swift uses artificial intelligence to improve clinical and economic outcomes in chronic and acute wound care, and is excited to deliver significant enhancements to its platform in 2024, including improved data security, enhanced interoperability, and enhanced device capabilities to improve the customer experience and drive excellence in healthcare technology.

Swift has built a market-leading wound care tool that improves outcomes for patients and streamlines busy workflows for providers, and this funding will enable us to expand our reach and enhance our technology to further revolutionise wound care and impact patient care,” said Brian Litten, CEO of Swift Medical.

en_GBEnglish (UK)